PDHX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.796800E-01
Normal-vs-Stage2
7.529200E-01
Normal-vs-Stage3
1.409250E-01
Normal-vs-Stage4
7.868200E-01
Stage1-vs-Stage2
7.206200E-01
Stage1-vs-Stage3
1.141220E-01
Stage1-vs-Stage4
7.922400E-01
Stage2-vs-Stage3
1.159040E-01
Stage2-vs-Stage4
9.712200E-01
Stage3-vs-Stage4
2.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.024200E-01
Normal-vs-AfricanAmerican
4.406200E-01
Normal-vs-Asian
9.768400E-01
Caucasian-vs-AfricanAmerican
5.177800E-01
Caucasian-vs-Asian
6.832000E-01
AfricanAmerican-vs-Asian
4.232600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.802200E-01
Normal-vs-Female
8.036200E-01
Male-vs-Female
9.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.801000E-01
Normal-vs-Age(41-60Yrs)
4.622800E-01
Normal-vs-Age(61-80Yrs)
9.579400E-01
Normal-vs-Age(81-100Yrs)
8.612400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.540800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.380600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.877600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.599700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.682200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.581600E-01
Normal-vs-Daily Drinker
8.797600E-01
Normal-vs-Weekly Drinker
7.976800E-01
Normal-vs-Occasional Drinker
4.874200E-01
Normal-vs-Social Drinker
7.484800E-01
Non Drinker-vs-Daily Drinker
8.788000E-01
Non Drinker-vs-Weekly Drinker
7.227200E-01
Non Drinker-vs-Occasional Drinker
1.316190E-01
Non Drinker-vs-Social Drinker
5.224800E-01
Daily Drinker-vs-Weekly Drinker
7.983200E-01
Daily Drinker-vs-Occasional Drinker
8.683900E-02
Daily Drinker-vs-Social Drinker
3.922600E-01
Weekly Drinker-vs-Occasional Drinker
1.122400E-01
Weekly Drinker-vs-Social Drinker
3.587200E-01
Occasional Drinker-vs-Social Drinker
4.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.135620E-01
Normal-vs-Grade 2
4.659800E-02
Normal-vs-Grade 3
4.751900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.681610E-01
Grade 1-vs-Grade 3
8.792200E-02
Grade 1-vs-Grade 4
1.135620E-01
Grade 2-vs-Grade 3
5.077800E-01
Grade 2-vs-Grade 4
4.659800E-02
Grade 3-vs-Grade 4
4.751900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.197600E-01
Normal-vs-NonDiabetic
8.109400E-01
Diabetic-vs-NonDiabetic
1.410550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.117800E-01
Normal-vs-NoPancreatitis
8.981000E-01
Pancreatitis-vs-NoPancreatitis
8.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.533000E-01
Normal-vs-N1
7.984800E-01
N0-vs-N1
9.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.890800E-01
Normal-vs-TP53-NonMutant
8.424800E-01
TP53-Mutant-vs-TP53-NonMutant
3.321700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
